Classification of HIV protease inhibitors on the basis of their antiviral potency using radial basis function neural networks

HIV protease inhibitors are being used as frontline therapy in the treatment of HIV patients. Multi-drug-resistant HIV mutant strains are emerging with the initial aggressive multi-drug treatment of HIV patients. This necessitates continued search for novel inhibitors of viral replication. These protease inhibitors may further be useful as pharmacological agents for inhibition of other viral replication. Classification models of HIV Protease inhibitors are developed using a data set of 123 compounds containing several heterocycles. Their inhibitory concentrations expressed as log (IC50) ranged from −1.52 to 2.12 log units. The dataset was divided into active and inactive classes on the basis of their antiviral potency. Initially a two-class problem (active, inactive) is explored using k-nearest neighbor approach. In order to introduce non-linearity in the classifier different approaches were investigated. This led to the goal of a fast, simple, minimum user input, radial basis function neural network (RBFNN) classifier development. Then the same two-class problem was resolved using the (RBFNN) classifier. A genetic algorithm with RBFNN fitness evaluator was used to search for the optimum descriptor subsets. The application of majority rules was also tested for the RBFNN classification. The best six descriptor model found by the new cost function showed predictive ability in the high 80% range for an external prediction set.

[1]  John E. Moody,et al.  Towards Faster Stochastic Gradient Search , 1991, NIPS.

[2]  D. B. Boyd.  Quantum Chemistry Program Exchange. , 1999, Journal of molecular graphics & modelling.

[3]  Tong Zhang,et al.  Text Categorization Based on Regularized Linear Classification Methods , 2001, Information Retrieval.

[4]  Kimito Funatsu,et al.  GA Strategy for Variable Selection in QSAR Studies: GA-Based Region Selection for CoMFA Modeling , 1998, J. Chem. Inf. Comput. Sci..

[5]  Bernhard E. Boser,et al.  A training algorithm for optimal margin classifiers , 1992, COLT '92.

[6]  Joel Morris,et al.  Asymmetric Syntheses and Absolute Stereochemistry of 5,6-Dihydro-α-pyrones, A New Class of Potent HIV Protease Inhibitors , 1997 .

[7]  W. Howe,et al.  Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. , 1996, Journal of medicinal chemistry.

[8]  Richard O. Duda,et al.  Pattern classification and scene analysis , 1974, A Wiley-Interscience publication.

[9]  S. Deeks.  Failure of HIV-1 protease inhibitors to fully suppress viral replication. Implications for salvage therapy. , 1999, Advances in experimental medicine and biology.

[10]  Lemont B. Kier,et al.  The E-State as an Extended Free Valence , 1997, J. Chem. Inf. Comput. Sci..

[11]  S. Hammer,et al.  Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. , 1998, JAMA.

[12]  M. Battegay,et al.  Salvage treatment against human immunodeficiency virus. , 1999, Annals of medicine.

[13]  G. Zeikus,et al.  5,6-Dihydropyran-2-ones possessing various sulfonyl functionalities: potent nonpeptidic inhibitors of HIV protease. , 2000, Journal of medicinal chemistry.

[14]  Friedhelm Schwenker,et al.  Three learning phases for radial-basis-function networks , 2001, Neural Networks.

[15]  A. Balaban.  Highly discriminating distance-based topological index , 1982 .

[16]  Brian T. Luke,et al.  Evolutionary Programming Applied to the Development of Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[17]  S E Hagen,et al.  4-Hydroxy-5,6-dihydropyrones as inhibitors of HIV protease: the effect of heterocyclic substituents at C-6 on antiviral potency and pharmacokinetic parameters. , 2001, Journal of medicinal chemistry.

[18]  A. Bondi.  van der Waals Volumes and Radii , 1964 .

[19]  D. Broomhead,et al.  Radial Basis Functions, Multi-Variable Functional Interpolation and Adaptive Networks , 1988 .

[20]  A. J. Stuper,et al.  Computer assisted studies of chemical structure and biological function , 1979 .

[21]  P. Jadhav,et al.  Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. , 1997, Journal of medicinal chemistry.

[22]  E. Lunney,et al.  Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the profound effect of polarity on antiviral activity. , 1997, Journal of medicinal chemistry.

[23]  New series of potent, orally bioavailable, non-peptidic cyclic sulfones as HIV-1 protease inhibitors. , 1996, Journal of medicinal chemistry.

[24]  William J. Phillips,et al.  Speech recognition techniques using RBF networks , 1995, IEEE WESCANEX 95. Communications, Power, and Computing. Conference Proceedings.

[25]  Belur V. Dasarathy,et al.  Nearest neighbor (NN) norms: NN pattern classification techniques , 1991 .

[26]  P. Jurs,et al.  Development and use of charged partial surface area structural descriptors in computer-assisted quantitative structure-property relationship studies , 1990 .

[27]  M. Lederman,et al.  Human immunodeficiency virus 1 protease inhibitors in clinical practice: predictors of virological outcome. , 1999, Archives of internal medicine.

[28]  A. K. Madan,et al.  Superpendentic Index: A Novel Topological Descriptor for Predicting Biological Activity , 1999, J. Chem. Inf. Comput. Sci..

[29]  George D. Magoulas,et al.  Effective Backpropagation Training with Variable Stepsize , 1997, Neural Networks.

[30]  Federico Girosi,et al.  An improved training algorithm for support vector machines , 1997, Neural Networks for Signal Processing VII. Proceedings of the 1997 IEEE Signal Processing Society Workshop.